Journal article
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice
S Akazawa, L Mackin, G Jhala, S Fynch, T Catterall, C Selck, KL Graham, B Krishnamurthy, EG Pappas, CTJ Kwong, APR Sutherland, TWH Kay, TC Brodnicki, HE Thomas
Diabetologia | Published : 2021
Abstract
Aims/hypothesis: Stimulator of IFN genes (STING) is a central hub for cytosolic nucleic acid sensing and its activation results in upregulation of type I IFN production in innate immune cells. A type I IFN gene signature seen before the onset of type 1 diabetes has been suggested as a driver of disease initiation both in humans and in the NOD mouse model. A possible source of type I IFN is through activation of the STING pathway. Recent studies suggest that STING also has antiproliferative and proapoptotic functions in T cells that are independent of IFN. To investigate whether STING is involved in autoimmune diabetes, we examined the impact of genetic deletion of STING in NOD mice. Methods:..
View full abstractGrants
Awarded by State Government of Victoria
Funding Acknowledgements
This work was funded by National Health and Medical Research Council of Australia (NHMRC) Program grants (GNT1126237 and GNT1150425), a JDRF Innovation Award (1-INO-2016-218-A-N) and fellowships from the JDRF (3-PDF-2017-379-A-N) andManpei Suzuki Diabetes Foundation (SA). The St Vincent's Institute receives support from the Operational Infrastructure Support Scheme of the Government of Victoria.